Log in

NASDAQ:CYNO - Cynosure Stock Price, Forecast & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
$66.00
0.00 (0.00 %)
(As of 03/23/2017)
Add
Today's Range
$66.00
Now: $66.00
$66.00
50-Day Range N/A
52-Week Range
$39.90
Now: $66.00
$66.65
VolumeN/A
Average Volume1.24 million shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Cynosure, Inc develops, manufactures and markets aesthetic treatment systems that enable plastic surgeons, dermatologists and other medical practitioners to perform non-invasive and minimally invasive procedures to remove hair, treat vascular and benign pigmented lesions, remove multi-colored tattoos, revitalize the skin, reduce fat through laser lipolysis, reduce cellulite, clear nails infected by toe fungus, ablate sweat glands and improve women's health. Read More…

Industry, Sector and Symbol

Industry N/A
Sub-IndustryHealth Care Equipment
SectorN/A
Current SymbolNASDAQ:CYNO
CUSIP23257720
Phone+1-978-2564200

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

Receive CYNO News and Ratings via Email

Sign-up to receive the latest news and ratings for CYNO and its competitors with MarketBeat's FREE daily newsletter.


Cynosure (NASDAQ:CYNO) Frequently Asked Questions

What is Cynosure's stock symbol?

Cynosure trades on the NASDAQ under the ticker symbol "CYNO."

How were Cynosure's earnings last quarter?

Cynosure, Inc. (NASDAQ:CYNO) released its earnings results on Tuesday, July, 26th. The medical equipment provider reported $0.36 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of $0.29 by $0.07. The medical equipment provider earned $110.30 million during the quarter, compared to analyst estimates of $101.31 million. The business's quarterly revenue was up 31.8% compared to the same quarter last year. During the same period last year, the business earned $0.30 EPS. View Cynosure's Earnings History.

Has Cynosure been receiving favorable news coverage?

Media coverage about CYNO stock has trended extremely negative recently, according to InfoTrie Sentiment Analysis. The research group scores the sentiment of press coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Cynosure earned a coverage optimism score of -4.5 on InfoTrie's scale. They also gave media stories about the medical equipment provider a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an impact on the company's share price in the immediate future. View News Stories for Cynosure.

Who are some of Cynosure's key competitors?

What other stocks do shareholders of Cynosure own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cynosure investors own include Global Blood Therapeutics (GBT), Hawkins (HWKN), DHT (DHT), NVIDIA (NVDA), CA (CA), Golar LNG Partners (GMLP), Micron Technology (MU), Endologix (ELGX), BlackRock (BLK) and Chipotle Mexican Grill (CMG).

What is Cynosure's stock price today?

One share of CYNO stock can currently be purchased for approximately $66.00.

What is Cynosure's official website?

The official website for Cynosure is http://www.cynosure.com/.

How can I contact Cynosure?

Cynosure's mailing address is 5 Carlisle Rd, WESTFORD, MA 01886-3601, United States. The medical equipment provider can be reached via phone at +1-978-2564200.


MarketBeat Community Rating for Cynosure (NASDAQ CYNO)

Community Ranking:  3.1 out of 5 (star star star)
Outperform Votes:  316 (Vote Outperform)
Underperform Votes:  195 (Vote Underperform)
Total Votes:  511
MarketBeat's community ratings are surveys of what our community members think about Cynosure and other stocks. Vote "Outperform" if you believe CYNO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CYNO will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/26/2020 by MarketBeat.com Staff

Featured Article: Accumulation/Distribution

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel